These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


100 related items for PubMed ID: 21835

  • 1. [Biochemical studies of acebutolol-the beta1 specificity of acebutolol (author's transl)].
    Hamada Y, Sato I, Ito K, Kuwabara S, Kojima Y.
    Nihon Yakurigaku Zasshi; 1977 Jul; 73(5):591-6. PubMed ID: 21835
    [Abstract] [Full Text] [Related]

  • 2. Metabolic effects of various beta-adrenoceptor blocking agents in rats and dogs.
    Traunecker W.
    Arzneimittelforschung; 1985 Jul; 35(1A):376-82. PubMed ID: 2859032
    [Abstract] [Full Text] [Related]

  • 3. Cardiac effects of beta-adrenergic receptor antagonists: beta-moderators versus beta-blockers.
    Dhalla NS, Alto LE, Pierce GN, Daly MJ, Dhillon KS, Compier R, Guerin A.
    Clin Ther; 1980 Jul; 3(4):254-9. PubMed ID: 6115715
    [Abstract] [Full Text] [Related]

  • 4. [Effect of acebutolol, an adrenergic beta receptor blocker, on plasma free fatty acids fluctuations caused by isoproterenol administration].
    Nishihara K, Suzuki Y, Kobayashi A, Abe N, Kanagawa T.
    Kokyu To Junkan; 1983 Nov; 31(11):1167-71. PubMed ID: 6145198
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of acebutolol, a cardioselective beta-adrenoceptor blocking agent, on the blood pressure in rats (author's transl)].
    Takami N, Sugawara K, Ozaki M.
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):747-54. PubMed ID: 44260
    [Abstract] [Full Text] [Related]

  • 6. [Experimental analysis of the cardiovascular effects of acebutolol, a drug with beta-adrenolytic activity].
    Marmo E, Rossi F, Lampa E, Chieppa S, Apolito A, Del Vecchio F.
    Arch Sci Med (Torino); 1978 Oct; 135(1):57-78. PubMed ID: 25058
    [Abstract] [Full Text] [Related]

  • 7. Effect of an original piperazine derivative of tetraline on the adrenergically mediated metabolic responses in cats and rats.
    Bogoslovova T, Staneva-Stoytcheva D.
    Acta Physiol Pharmacol Bulg; 1988 Oct; 14(4):55-64. PubMed ID: 2907712
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacology of acebutolol in animals].
    Basil B.
    Nouv Presse Med; 1975 Dec 31; 4(46 Suppl):3217-21. PubMed ID: 1219628
    [Abstract] [Full Text] [Related]

  • 9. Metabolic profile of beta-adrenoceptor-blocking action of befunolol.
    Maruyama Y, Awaji T, Inoue M, Takeo S.
    Arch Int Pharmacodyn Ther; 1991 Dec 31; 311():73-88. PubMed ID: 1686392
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the bronchoconstrictor and beta-adrenoceptor blocking activity of propranolol and acebutolol.
    MacLagan J, Ney UM.
    Br J Pharmacol; 1980 Feb 31; 68(2):196-8. PubMed ID: 6101978
    [Abstract] [Full Text] [Related]

  • 11. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
    Bowden CR, Marchione CS.
    J Pharmacol Exp Ther; 1989 Nov 31; 251(2):599-605. PubMed ID: 2572694
    [Abstract] [Full Text] [Related]

  • 12. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
    Nishimura T, Kita S, Abiko Y.
    J Pharmacol Exp Ther; 1983 Aug 31; 226(2):595-602. PubMed ID: 6688273
    [Abstract] [Full Text] [Related]

  • 13. Comparative beta-blocking potencies of acebutolol and propranolol relative to plasma drug levels.
    Collett JT, Hendrickson JA, Chew CY, Shah PM, Laddu AR, Singh BN.
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov 31; 19(11):473-8. PubMed ID: 6117519
    [Abstract] [Full Text] [Related]

  • 14. Effect of catecholamines and adrenergic antagonists on blood glucose, free fatty acids and liver glycogen levels in fed rats.
    Bugajski J, Hano J, Zdebska A.
    Pol J Pharmacol Pharm; 1978 Nov 31; 30(6):799-818. PubMed ID: 755244
    [Abstract] [Full Text] [Related]

  • 15. [The effects of acebutolol on endocrine and metabolic reactions induced by acute hypoglycaemia. Study in normal subjects and in insulin-dependent diabetics (author's transl)].
    Passa P, Gauville C, Bentz F, Assan R, Canivet J.
    Presse Med (1893); 1979 Dec 10; 8(48):3951-5. PubMed ID: 394144
    [Abstract] [Full Text] [Related]

  • 16. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT, Levy GP.
    Br J Clin Pharmacol; 1976 Aug 10; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [Abstract] [Full Text] [Related]

  • 17. [Effects of adrenergic blockade on adipose tissue lipolysis provoked in cats and humans by intravenous perfusion of isoprenaline].
    Ashford A.
    Nouv Presse Med; 1975 Dec 31; 4(46 Suppl):3265-7. PubMed ID: 3767
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of acebutolol and practolol on the lipolytic response to isoprenaline.
    Gibbons DO, Lant AF, Ashford A, Collins RF, Pinder S.
    Br J Clin Pharmacol; 1976 Feb 31; 3(1):177-84. PubMed ID: 973938
    [Abstract] [Full Text] [Related]

  • 19. Beta-adrenoblocking activity of a new derivative of 2-aminotetraline based on some metabolic responses in cats and rats.
    Bogoslovova T, Staneva-Stoytcheva D.
    Acta Physiol Pharmacol Bulg; 1988 Feb 31; 14(3):39-45. PubMed ID: 2906208
    [Abstract] [Full Text] [Related]

  • 20. [Influence of a pressure agent on blood concentrations of glucose, lactate, pyruvate and free fatty acids (author's transl)].
    Rettig G, Sternitzke N, Schieffer H, Hoffmann W, Bette L.
    Arzneimittelforschung; 1976 Feb 31; 26(6):1223-7. PubMed ID: 989422
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.